Pages that link to "Q35929180"
Jump to navigation
Jump to search
The following pages link to Hepatocellular carcinoma: current management and future trends. (Q35929180):
Displaying 50 items.
- A novel magnetic nanoparticle drug carrier for enhanced cancer chemotherapy (Q28484262) (← links)
- 5-Fluorouracil nanoparticles inhibit hepatocellular carcinoma via activation of the p53 pathway in the orthotopic transplant mouse model (Q28484409) (← links)
- Gold(III) compound is a novel chemocytotoxic agent for hepatocellular carcinoma (Q28580848) (← links)
- Liver tumor ablation (Q33210169) (← links)
- A phase II study of pemetrexed in patients with advanced hepatocellular carcinoma (Q33378789) (← links)
- Pilot study of combination chemotherapy of S-1, a novel oral DPD inhibitor, and interferon-alpha for advanced hepatocellular carcinoma with extrahepatic metastasis (Q33378906) (← links)
- Phase II study of hepatic arterial infusion of a fine-powder formulation of cisplatin for advanced hepatocellular carcinoma (Q33379364) (← links)
- Nonresectable hepatocellular carcinoma: long-term toxicity in patients treated with transarterial chemoembolization--single-center experience. (Q33381184) (← links)
- Residual hepatocellular carcinoma after oxaliplatin treatment has increased metastatic potential in a nude mouse model and is attenuated by Songyou Yin. (Q33582751) (← links)
- Treatment Options of Metastatic Brain Tumors from Hepatocellular Carcinoma: Surgical Resection vs. Gamma Knife Radiosurgery vs. Whole Brain Radiation Therapy (Q33635364) (← links)
- In vitro radionuclide therapy and in vivo scintigraphic imaging of alpha-fetoprotein-producing hepatocellular carcinoma by targeted sodium iodide symporter gene expression. (Q33670033) (← links)
- Expression of angiopoietins, Tie2 and vascular endothelial growth factor in angiogenesis and progression of hepatocellular carcinoma (Q33866067) (← links)
- Symptom management in hepatocellular carcinoma (Q33897458) (← links)
- Quantitative multiparametric PROPELLER MRI of diethylnitrosamine-induced hepatocarcinogenesis in wister rat model (Q34001900) (← links)
- Fibroblast growth factor 19 expression correlates with tumor progression and poorer prognosis of hepatocellular carcinoma (Q34151946) (← links)
- Novel synergistic antitumor effects of rapamycin with bortezomib on hepatocellular carcinoma cells and orthotopic tumor model (Q34257851) (← links)
- Nuclear expression of the deubiquitinase CYLD is associated with improved survival in human hepatocellular carcinoma (Q34352254) (← links)
- Endothelial progenitor cells homing to the orthotopic implanted liver tumor of nude mice (Q34449054) (← links)
- Outcome of 1000 liver cancer patients evaluated at the UPMC Liver Cancer Center (Q34478383) (← links)
- Metformin reverses multidrug resistance in human hepatocellular carcinoma Bel‑7402/5‑fluorouracil cells (Q34487968) (← links)
- Growth Suppression of Human Hepatocellular Carcinoma Xenografts by a Monoclonal Antibody CH12 Directed to Epidermal Growth Factor Receptor Variant III (Q34568677) (← links)
- Suppression of natural killer cells by sorafenib contributes to prometastatic effects in hepatocellular carcinoma (Q34586486) (← links)
- Novel mechanism by which histone deacetylase inhibitors facilitate topoisomerase IIα degradation in hepatocellular carcinoma cells (Q34681633) (← links)
- Yttrium-90 microsphere radioembolization for the treatment of liver malignancies: a structured meta-analysis (Q34874473) (← links)
- Preclinical evaluation of 4-methylthiobutyl isothiocyanate on liver cancer and cancer stem cells with different p53 status (Q34926255) (← links)
- EGFRvIII mediates hepatocellular carcinoma cell invasion by promoting S100 calcium binding protein A11 expression (Q35078031) (← links)
- Knockdown of yes-associated protein inhibits proliferation and downregulates large tumor suppressor 1 expression in MHCC97H human hepatocellular carcinoma cells (Q35387908) (← links)
- Cell-surface Vimentin: A mislocalized protein for isolating csVimentin(+) CD133(-) novel stem-like hepatocellular carcinoma cells expressing EMT markers (Q35598363) (← links)
- Molecular imaging in tracking tumor stem-like cells (Q35909465) (← links)
- miR-200b restoration and DNA methyltransferase inhibitor block lung metastasis of mesenchymal-phenotype hepatocellular carcinoma (Q36143130) (← links)
- Selective tropism of liver stem cells to hepatocellular carcinoma in vivo (Q36178007) (← links)
- Antiangiogenic strategies in hepatocellular carcinoma: current status (Q36235557) (← links)
- Targeted p21WAF1/CIP1 activation by RNAa inhibits hepatocellular carcinoma cells (Q36297935) (← links)
- Expression quantitative trait loci for PAX8 contributes to the prognosis of hepatocellular carcinoma (Q36322057) (← links)
- Immunological treatment of liver tumors (Q36373254) (← links)
- Adenovirus-mediated combined anti-angiogenic and pro-apoptotic gene therapy enhances antitumor efficacy in hepatocellular carcinoma (Q36475833) (← links)
- Low expression of GNAI3 predicts poor prognosis in patients with HCC. (Q36493158) (← links)
- Herbal Compound "Songyou Yin" Renders Hepatocellular Carcinoma Sensitive to Oxaliplatin through Inhibition of Stemness (Q36522594) (← links)
- Interleukin-6-stimulated progranulin expression contributes to the malignancy of hepatocellular carcinoma cells by activating mTOR signaling (Q36583034) (← links)
- Multidisciplinary treatment of patients with hepatocellular carcinoma (Q36636630) (← links)
- Prognostic factors for pulmonary metastasectomy in hepatocellular carcinoma. (Q36676097) (← links)
- Galectin-1 induces hepatocellular carcinoma EMT and sorafenib resistance by activating FAK/PI3K/AKT signaling (Q36866377) (← links)
- Hepatocellular carcinoma: thyroid hormone promotes tumorigenicity through inducing cancer stem-like cell self-renewal (Q36898047) (← links)
- Wentilactone B induces G2/M phase arrest and apoptosis via the Ras/Raf/MAPK signaling pathway in human hepatoma SMMC-7721 cells (Q36973744) (← links)
- Transcatheter arterial chemoembolization of hepatocellular carcinoma: prevalence and causative factors of extrahepatic collateral arteries in 479 patients (Q37155118) (← links)
- In search of liver cancer stem cells. (Q37229285) (← links)
- Diet-induced hepatocellular carcinoma in genetically predisposed mice (Q37272350) (← links)
- Brain metastases from hepatocellular carcinoma: prognostic factors and outcome: brain metastasis from HCC. (Q37307634) (← links)
- Selective or targeted gene/drug delivery for liver tumors: advantages and current status of local delivery (Q37353096) (← links)
- UBAP2 negatively regulates the invasion of hepatocellular carcinoma cell by ubiquitinating and degradating Annexin A2. (Q37362811) (← links)